FDA Intends to Remove Unapproved Drugs From Market

Author: U.S. Food and Drug Administration
Published: 2011/03/02 - Updated: 2016/11/05
Topic: Pharmaceuticals - Publications List

Page Content: Synopsis - Introduction - Main

Synopsis: Regulators aim to take certain unapproved prescription medicines for cough cold and allergy symptoms off the U.S. market.

Introduction

Federal regulators aim to take certain unapproved prescription medicines intended to relieve cough, cold, and allergy symptoms off the U.S. market.

Main Item

According to the U.S. FDA these products may be risky to use because they have not been evaluated by FDA to assure that they are safe, effective, and of good quality.

FDA announced Wednesday that the agency intends to remove certain unapproved prescription medicines intended to relieve cough, cold, and allergy symptoms from the U.S. market.

FDA officials say they have numerous concerns about these products: some may have potentially risky combinations of ingredients, while others marketed as "timed-release" may release active ingredients too slowly, too quickly, or inconsistently.

FDA has also received reports that some of the products have names that look or sound similar to other products a problem that could contribute to medication errors.

Domestic and foreign establishments that manufacture, repack, or re-label drug products in the United States are required to register and list all of their commercially marketed drug products with the FDA.

Many drug firms do not update their drug listing information with FDA as required by law; consequently, the information in DRLS is both over- and under-inclusive.

To see a list of unapproved prescription cough, cold, and allergy products visit:

www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/ucm245106.htm

Explore Similar Topics

- Propofol, a widely used anesthetic, disrupts the brain's balance between stability and excitability.

- Information on pain management medications, from common anti-inflammatory drugs to powerful prescription analgesics such as codeine and morphine, designed to address diverse levels of pain intensity.

Citing Information and Page References

Disabled World (DW) is a comprehensive online resource providing information and news related to disabilities, assistive technologies, and accessibility. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): U.S. Food and Drug Administration. (2011, March 2 - Last revised: 2016, November 5). FDA Intends to Remove Unapproved Drugs From Market. Disabled World (DW). Retrieved February 12, 2025 from www.disabled-world.com/medical/pharmaceutical/unapproved-drugs.php

Permalink: <a href="https://www.disabled-world.com/medical/pharmaceutical/unapproved-drugs.php">FDA Intends to Remove Unapproved Drugs From Market</a>: Regulators aim to take certain unapproved prescription medicines for cough cold and allergy symptoms off the U.S. market.

While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.